Why ivermectin still matters
1:11:08–1:11:55 · 47s
Bret notes proposed objections to ivermectin’s mechanisms on cytoplasmic-replicating viruses, then argues its multi-pathway actions and safety profile still justify consideration.
1:11:08–1:11:55 · 47s
Bret notes proposed objections to ivermectin’s mechanisms on cytoplasmic-replicating viruses, then argues its multi-pathway actions and safety profile still justify consideration.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.